Save time and get answers to complex questions with AI chat
Is guselkumab off patent in u s?Albendazole side effects in humans?How much is mebendazole?Sun pharma bortezomib?Stribild expiry date?
See the DrugPatentWatch profile for reclast
Reclast (zoledronic acid) was approved by the U.S. FDA in February 2002 for osteoporosis in postmenopausal women (and it launched in 2002). If you meant its cancer-related use, that’s a separate, earlier indication under the related product Zometa.
Other Questions About Reclast :